Please use this identifier to cite or link to this item:
Title: Assessment of Bone Health Biomarker (ALP) after Treatment with Biofield Energy Treated DMEM in MG-63 Cells
Authors: Trivedi, Mahendra Kumar;Jana, Snehasis
subject: Biofield Energy;ALP;Osteoporosis;Osteosarcoma Cells;DMEM;Bone Health
Year: 15-Feb-2019
Publisher: Lupine Publishers
Citation: Mahendra Kumar Trivedi and Snehasis Jana. In vitro Evaluation of Immunomodulatory Effects of the Test Formulation by the Estimation of Natural Killer Cells and Phagocytosis Activities. Cell Cellular Lif Sci J 2019, 4(1): 000137.
Abstract: The aim was to examine the effect of Biofield Treated DMEM on bone health in MG-63 cells. Dulbecco’s Modified Eagle’s Medium was used as a test sample in this study and divided into two parts. First part received Biofield Treatment by Mahendra Kumar Trivedi and was labeled as the one-time Biofield Energy Treated (BT-I) DMEM, while the second part received two-times Biofield Treatment and denoted as BT-II. MTT assay was studied for cell viability, which was found as more than 73.9% in MG-63 cell line, which indicated with a safe and non-toxic profile. The bone health parameter, the level of ALP was significantly (p≤0.001) increased by 42.86% in both BT-I and BT-II groups compared with the untreated DMEM group. Thus, the data suggested that the Biofield Treated DMEM significantly improved ALP level, which can be used for the management of osteoporosis, deformed bones, bone and/or joint pain, rickets, osteoma, osteomalacia, aging, hormonal imbalance, and stress.
ISSN: 2638-6003
Appears in Collections:منابع مشترک

Items in HannanDL are protected by copyright, with all rights reserved, unless otherwise indicated.